This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Weiterführende Literatur
ABIM Foundation, American Board of Internal Medicine; ACP-ASIM Foundation et al (Hrsg) (2002) Medical professionalism in the new millennium: a physician charter. Ann Intern Med 136: 243–246
Campbell EG, Sowmya R, DesRoches CM et al (2010) Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med 170: 1820–1826
Gagnon MA, Lexchin J (2008) The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLOS Med 5: 29–33
Lieb K, Brandtönies S (2010) Eine Befragung niedergelassener Fachärzte zum Umgang mit Vertreterbesuchen der Pharmazeutischen Industrie. Dtsch. Arztebl. Int. 107: 392–398
Lo B, Field MJ (Hrsg) (2009) Conflict of interest in medical research, education, and practice. Kap 6: Conflicts of interest and medical practice. National Academies Press, Washington, 1. Aufl. S 166–188
Andere zitierte Literatur
Andersen M, Kragstrup J, Sondergaard J (2006) How conducting a clinical trial affects physician`s guideline adherence and drug preferences. JAMA 295: 2759–2764
Bowman MA, Pearle DL (1988) Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ 1988: 13–20
Campbell EG, Gruen RL, Mountford J et al (2007) A national survey of physician-industry relationships. N Engl J Med 356: 1742–1750
Chren M, Landefeld C (1994) Physicians` behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271: 684–689
Dohohue JM, Cevasco M, Rosenthal MB (2007) A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 357: 673–681
Fugh-Berman A, Ahari S (2007) Following the script: how drug reps make friends and influence doctors. PLoS Med 4(4): e150
Gebuhr K (2007) Der Pharmareferent in der Bewertung der Vertragsärzteschaft (Ergebnisse schriftlicher Befragungen vom Oktober 2006). Brendan Schmittmann Stiftung, Berlin.
Grande D, Frosch D, Perkins A, Kahn B (2009) Effect of exposure to small pharmaceutical promotional items on treatment preferences. Arch Intern Med 169: 887–893
Korenstein D, Keyhani S, Ross JS (2010) Physician attitudes toward industry. Arch Surg 145: 570–577
Korzilius H, Rieser S (2007) Pharmaberater: Für manche Fachmann, für andere Buhmann. Dtsch Ärztebl 104: 143–146
Morgan MA, Dana J, Loewenstein G et al (2006) Interactions of doctors with the pharmaceutical industry. J Med Ethics 32: 559–63
Orlowski JP, Wateska L (1992) The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. CHEST 102: 270–273
Randall ML, Rosenbaum JR (2003) Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Acad Psychiatr 29: 33–39
Sah S, Loewenstein G (2010) Effect of reminders of personal sacrifice and suggested rationalizations on residents`self-reported willingness to accept gifts. A randomized trial. JAMA 304: 1204–1211
Schneider J van, Arora V, Kasza K et al (2006) Residents’ perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med 81: 595–602
Spurling GK, Mansfield PR, Montgomery BD et al (2010) Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med 7: 1–22, e1000352
Steinman M, Shlipak M, MacPhee S (2001) Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110: 551–557
Sutherland JM, Fisher ES, Skinner JS (2009) Getting past denial – the high cost of health care in the United States. N Engl J Med 361: 1227–1230
Tattersall MHN, Dimoska A, Gan K (2009) Patients expect transparency in doctors` relationships with the pharmaceutical industry. Med J Austr 190: 65–68
Wang AT, McCoy CP, Murad MH, Montori VM (2010) Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 340: c1344
Watkins C, Harvey I, Carthy P et al (2003) Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Healthc12: 29–34
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wiesner, A., Lieb, K. (2011). Interessenkonflikte durch Arzt-Industrie-Kontakte in Praxis und Klinik und Vorschläge zu deren Reduzierung. In: Lieb, K., Klemperer, D., Ludwig, WD. (eds) Interessenkonflikte in der Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19842-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-19842-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19841-0
Online ISBN: 978-3-642-19842-7
eBook Packages: Medicine (German Language)